Table 3.
Clinical characteristics, treatment, and maternal outcomes of the database.
| Variables | Percentile | Variables | Percentile |
|---|---|---|---|
| Age (y) | 31.1 ± 6.6 | Location of gestational sac | N = 56 |
| Previous uterine surgery | N = 51 | Fundus | 17 (30.4%) |
| No or <2 times | 28 (50.0%) | Anterior wall | 7 (12.5%) |
| ≥2 times | 23 (41.1%) | Posterior wall | 20 (35.7%) |
| Gestational age (weeks) | 10.0 ± 5.4 (54) | Left side of the uterus | 6 (10.7%) |
| ≤ 10 | 39 | Right side of the uterus | 6 (10.7%) |
| >10 | 15 | Methods of treatment | N = 56 |
| Methods of Conception | N = 56 | Expectant treatment | 3 (5.4%) |
| Nature | 7 (12.5%) | Methotrexate | 4 (7.1%) |
| ART | 49 (87.5%) | Laparoscopic surgery | 20 (35.7%) |
| Serum β-HCG level (IU/L) | 18249.4 (38) | with hysteroscopy | 6 |
| Diagnosis time | N = 56 | Laparotomy surgery | 23 (41.1%) |
| Preoperative | 31 (55.4%) | with UAE/UA ligation | 1/1 |
| Intra or postoperative | 25 (44.6%) | with ABO | 2 |
| Diagnosis methods | N = 56 | Surgical enucleation | 3 (5.4%) |
| US | 21 | Methotrexate + potassium | 1 |
| MRI | 10 | UAE | 1 |
| Operation or pathology | 25 | Hysteroscopy | 1 |
| Intraoperative blood loss (ml) | 483.0 (27) | Hysterectomy | 8 (14.3%) |
| Blood transfusion | 3 (50) | Uterine rupture | 9 (16.1%) |
| Fertility outcomes | N = 17 | ||
| Not desire to fertility | 7 | Pregnancy (before delivery) | 2 |
| Desire to fertility | 10 | Successfully delivery | 4 |
| Failure | 3 | Term birth | 3 |
| Success | 6 | Preterm birth | 1 |
| Preparing | 1 | Recurrence of IEP | 1 |
NA, not applicable; HCG, human chorionic gonadotrophin; US, ultrasound; MRI, magnetic resonance imaging; UAE, uterine artery embolization; ABO, aorta balloon occlusion; IEP, intramural ectopic pregnancy.